Total Funding
6
Total FundingDebt Financing raised
Growth Score
pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
580472
LoneStar Heart is a biomedical company developing new therapies to preserve and restore adequate functioning of a human heart.
Andy G. Hinson: Vice President, Clinical and Regulatory AffairsPast Role: Procter & Gamble Company, Senior Manager of Medical and Scientific Affairs- Olav Bergheim: Executive Chairman of the Board & Board of DirectorsPast Role: Edwards Lifesciences, Corporate VP / President
About the Company
LoneStar Heart is a biomedical company developing new therapies to preserve and restore adequate heart function in patients with Advanced Heart Failure (HF). Based on its integrated card mechanical and biomolecular technologies, the privately-held company is developing a broad portfolio of products to restore the failing heart’s structure and
function in collaboration with the University of Texas Southwestern Medical Center, Texas Heart Institute, and a global network of leading clinicians. These products include Algisyl-LVR, small molecule cardiac stem-cell modulators, and cellular and genetic therapies delivered as stand-alone treatments, or in combination with the company’s proprietary biopolymer hydrogel matrix system.
